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Abstract
Introduction. Although the human umbilical cord (UC) has been previously considered a medical waste, its use 
as a main source of fetal stem cells for regenerative medicine applications has increased over the past few years. 
The aim of the study was to assess the impact of the maternal age on the expression of mesenchymal stem cells 
(MSC) markers CD105 and CD29 in the different areas of human UC.
Material and methods. In this comparative cross sectional study, one hundred term UCs from five maternal age groups 
(20–45 years) were collected after delivery from healthy mothers and were processed to assess both immuno- and 
gene expression of CD105 and CD29 surface antigen markers using immunohistochemical and RT-PCR techniques. 
Results. The immunoexpression of CD105 and CD29 in the amniotic membrane (AM) and Wharton’s jelly 
(WJ), the umbilical artery (UA) and the umbilical vein (UV) showed significant negative correlation with the 
maternal age (p < 0.001). Reduced amount of cells as well as the studied MSC markers and their gene expression 
levels were documented in older age mothers. CD105-positive MSCs were more abundant in the UA, whereas 
CD29-positive MSCs were more abundant in the AM and WJ.
Conclusion. The decreased expression of CD105 and CD29 MSCs markers with age suggests that selective isolation 
of MSCs from Wharton’s jelly, umbilical artery or umbilical vein of younger mothers should be recommended. 
(Folia Histochemica et Cytobiologica 2015, Vol. 53, No. 3, 259–271)
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Introduction
Studies carried out during the last decades strongly 
supported the concept that the umbilical cord (UC) is 
an important stem cell source for biomedical research 
and clinical applications [1]. The use of stem cells 
from fetal, cord blood and extra-embryonic tissues 
for regenerative medicine applications has increased 
over the past decade. Moreover, because the fetal 
stem cells can be expanded to very large numbers 
compared with the adult stem cells, they are ideal 
candidates for seeding scaffolds and matrices used 
for tissue engineering applications such as the repair 
of hollow and solid organs [2]. The UC vessels (one 
vein and two arteries) and the surrounding mucous 
connective tissue named Wharton’s jelly (WJ) are 
derived from the embryonic and/or extra-embryonic 
mesoderm. It was speculated that the UC matrix ma-
terial is derived from a primitive mesenchyme, which 
is in a transition state towards the adult bone marrow 
mesenchyme [3]. 
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Human mesenchymal stem cells (MSCs) have been 
identified and isolated from sub-endothelial layer of 
umbilical vein (UV) [4], Wharton’s jelly of the umbi-
lical cord [5, 6] and umbilical cord perivascular layer 
[7]. These cells are commonly characterized by the ex-
pression, in ≥ 95% of the MSC population, of CD105, 
CD73, CD90 CD29, CD44, CD51 and CD71 mem-
brane antigens, and the lack of expression of CD45, 
CD34, CD14, CD11b, CD79a or CD19 and HLA 
class II molecules [8, 9]. It remains unclear whether 
these cells, isolated from UV, WJ and UA represent 
distinct cell populations [10]. It was reported that the 
MSCs isolated from WJ share similar properties with 
other cord blood MSCs as well as adult bone marrow 
MSCs in relation to the expression of markers, differ-
entiation potential and cytokines’ production [5, 11].
The umbilical cord mesenchymal stem cells 
(UCMSCs) have several advantages making them at-
tractive to the regenerative medicine such as availability, 
fewer ethical consideration and favorable therapeutic 
potential [13]. The MSCs of the WJ were specifically 
investigated in the in vitro and pre-clinical studies for 
their clinical translational potential [5, 12, 14].
Many levels of regulation in response to local, 
systemic, and environmental factors regulate stem 
cell behavior [15]. Evidence from several tissues also 
suggests that the stem cell functional output is altered 
during aging [16]. The effect of aging on the regener-
ative ability of living organisms and its impact on bio-
logical activities has been the focus of many previous 
studies [17, 18] but few, if any, authors have investigat-
ed the effect of age on either fetal stem cells in general 
or specifically on umbilical cord stem cells. Therefore, 
this study aimed to assess the impact of maternal 
age on the expression of some MSCs surface antigen 
markers such as CD105 and CD29 in Wharton’s 
jelly, the umbilical artery and the umbilical vein of 
the term human umbilical cord. We hypothesized that 
MSCs marker expression is reduced in umbilical cords 
of older mothers compared to the younger ones and 
this reduction is attributed to reduced gene expression 
as well as cell number.
Material and methods
Patients’ selection. The present study was approved by the 
Biomedical Research Ethics Committee of the Faculty of 
Medicine of King Abdulaziz University in Jeddah, Saudi 
Arabia, and informed consents signed by all participants 
were obtained. As this was the first study aimed at assessing 
the impact of maternal age on the stem cell expression in 
umbilical cord and because of the limited resources, a total 
of 100 full-term Saudi pregnant mothers were included in 
this study. The physiological deliveries or those through 
Cesarean sections done in the Department of Obstetrics 
and Gynecology at King Abdulaziz University Hospital, 
Jeddah, between June, 2012 and May, 2013 were included 
in this study. The eligibility criteria for the cases were the 
following: full term (≥ C37 weeks) pregnant female aged 
twenty years or higher. The gestational age was confirmed 
using the date of the last menstrual period and through 
an ultrasound examination performed 11–13 weeks after 
gestation [19] obtained from patient’s medical records. To 
ensure that only normal pregnancies were included in the 
study, the exclusion criteria were the following: pregnancies 
complicated by gestational diabetes, preeclampsia, or any 
other chronic diseases. A total of 20 full-term freshly deli-
vered UCs were collected in each of the maternal age groups: 
A (20–25 years), B (26–30 years), C (31–35 years), D (36–40 
years) and E (41–45 years). The predictor, in this study, is 
the maternal age while the immuno- and gene-expression of 
stem cell markers are the outcome variables. The potential 
confounders were eliminated through the exclusion criteria.
Tissue sampling. Each UC collected at the time of deli-
very was weighted, washed with phosphate-buffered saline 
(PBS) (pH = 7.4, BDH, Poole, UK), injected with formalin 
through the umbilical vein, preserved in formalin and then 
transferred to the laboratory. The UC was separated from 
the placenta at its insertion; then the proximal part of 5 cm 
length was taken and further sectioned into 0.5 cm longitu-
dinal sections. The latter were processed to obtain paraffin 
blocks which were cut serially (4 μm thick), mounted on 
glass slides and stained with hematoxylin and eosin [20].
Immunohistochemistry. Human endoglin/CD105 antibody 
(Leica Bio Systems; Newcastle, UK, diluted to 15 μg/mL), 
human integrin b1/CD29 antibody (Leica Bio Systems, 
diluted to 15 μg/mL), human CD34 antibody (Leica Bio 
Systems, diluted to 25 μg/mL) and HRP-conjugated primary 
antibody dilution buffer (R & D System, Minneapolis, MN, 
USA) were used. The corresponding biotinylated conjugated 
secondary antibody from a Dako staining system was also 
used (Dako, Glostrup, Denmark).
The immunohistochemical staining were performed on 
paraffin-embedded tissue sections according to the proce-
dure previously described [21–23]. Briefly, the sections were 
deparaffinized using xylene and ethanol. Antigen retrieval 
was achieved by boiling the tissue slides with 0.01 M citric 
buffer in a microwave for 5 min. Hydrogen peroxide (0.5%) 
was applied at room temperature (RT) for 10 min to quench 
the endogenous peroxidase activity. After blocking for 
10 min with 10% horse serum-Tris buffer for 20 minutes at 
RT, the sections were incubated with the primary antibody 
at the dilution noted above at RT for 2 h and, thereafter, 
with the secondary antibody for 2 h. Slides stained only with 
a non-specific IgG were used as negative controls. The 
nuclei were counterstained with Mayer’s hematoxylin. The 
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brown DAB staining of the nuclei, cytoplasm or both was 
considered a positive staining. An Olympus microscope 
BX-51 (Olympus, Tokyo, Japan) with a digital camera con-
nected to a computer was used to photograph the images. 
In order to quantify the immunoexpression of the markers, 
the area percentage (AP) of the brown label was assessed 
as an indicator of the cell number while the mean intensity 
(MI) of the reaction was assessed as an indicator of the 
expression level. Both parameters were assessed by an inves-
tigator who was not aware with the age group examined, in 
20 non-overlapping fields in each sample with a 40× objective 
lens and a 10× ocular lens using the Pro Plus image analysis 
software version 6.0 (Cybernetics, Warrendale, PA, USA) 
as was described by Decaestecker et al. [24]. 
Gene expression analysis. Quantitative Real Time Polyme-
rase Chain Reaction (QPCR) was performed in Molecular 
Biology Lab, Zagazig University, Zagazig, Egypt, to detect the 
expression of human CD105 and CD29 genes in all examined 
groups relative to the housekeeping gene, b-actin. Specimens 
from the different studied areas of the UC were rapidly dis-
sected immediately after delivery and stored at −80°C until 
assays were performed. Total RNA was isolated using an 
RNeasy Mini kit including DNase I digestion following the 
manufacturer’s protocol (#74104, Qiagen, Hilden, Germany). 
The RNA was then reverse transcribed using Quantiscript 
reverse transcriptase (Quanti Tect Reverse Transcription 
Kit (#205310, Qiagen) and quantitative RT-PCR analysis 
was performed with a (Rotor-Gene Q 2plex, Qiagen) and 
SYBR Green master mix (Roche Diagnostics, Carlsbad, CA, 
USA). The following primers were used for analysis: CD29, 
5’-AATGGAGTGAATGGGACAGG-3’ and 5’-TCTGT-
GAAGCCCAGAGGTTT-3’ and CD105, 5’-TCTACCTC-
CACCATGCCAAGT-3’ and 5’-TTTTTCCGCTGTGGT-
GATGA-3’; b-actin, 5’-TGTCACCAACTGGGACGATA-3’, 
and 5’-GGGGTGTTGAAGGTCTCAAA-3’. The mRNA 
concentrations of all detected genes were normalized and 
represented as a ratio against the expression of ACTB. The 
software (Rotor Gene Q, version 2.0.2, Build 4, Qiagen) was 
used for data analysis.
Statistical analysis. The data was analyzed using the Sta-
tistical Package for the Social Sciences (SPSS, version 16, 
Chicago, IL, USA) software. For the analysis of quantitative 
non-parametric data, Kruskal–Wallis analysis of variance 
(ANOVA) followed by a post-hoc test (based on the Dun-
nett’s C procedure) was used to analyze each pair of groups 
to avoid a multiple-comparison effect. For the quantitative 
parametric data, the different groups were compared using 
ANOVA (F-test), followed by a Bonferroni post-hoc test. 
Results were expressed as mean ± standard deviation (SD) 
as well as the lower and upper bounds of 95% confidence 
interval for mean. The correlation of the maternal age with 
the immunoexpression of MSCs markers in different parts 
of full-term human umbilical cord was determined using 
Pearson’s correlation. A p value less than 0.05 was consi-
dered to be statistically significant.
Results
Mother’s age and fetal mass
The mean age of the mothers included in this study 
was 32.2 ± 7.1 years. There was a significant decrease 
in fetal weights in group D (35–40 years) compared 
with group A (20–25 years) (Table 1). A significant 
negative correlation (r = 0.34, p = 0.001) was found 
between the maternal age and the fetal weights.
Immunohistochemical analysis of CD105  
and CD29 expression
Figure 1 presents microphotographs of sections of 
umbilical cord (UC) derived from mothers of various 
ages. The sections were stained by H & E and immu-
nohistochemistry. It was found that UCMSCs showed 
CD105 and CD29 immunoexpression while they did 
not express CD34 surface antigen marker (data not 
shown). MSCs of AM and WJ showed strong cytoplas-
mic and nuclear expression of CD105 in groups A, B 
and C and a weak expression in the groups D and E. 
The MSCs of AM showed moderate cytoplasmic CD29 
expression in groups A and B and a weak cytoplasmic 
immunoreactivity in groups D and E (Figure 1).
Figure 2 presents immunoreactivity of CD105 and 
CD29 molecules in the wall of umbilical artery (UA). 
Table 1. Maternal age and fetal mass in the different age 
groups
Age groups Mother’s age  
(years)
Fetal mass  
(kg)
Group A  
(20–25 years, n = 20)
22.3 ± 1.7 
(21.5–23.1)
3.2 ± 0.55 
(2.9–3.5)
Group B  
(26–30 years, n = 20)
27.3 ± 1.3 
(26.7–27.9)
3.2 ± 0.48 
(3.1–3.5)
Group C  
(31–35 years, n = 20)
32.6 ± 1.4 
(31.8–33.2)
3.1 ± 0.5 
(2.8–3.3)
Group D  
(36–40 years, n = 20)
36.4 ± 1.1 
(36.3–37.4)
2.5 ± 0.3*, &, # 
(2.3–2.7)
Group E
(41–45 years, n = 20)
42 ± 1.7
(41.2–42.8)
2.9 ± 0.69
(2.5–3.2)
Total
(n = 100)
32.2 ± 7.1
(30.8–33.6)
3.1 ± 0.58
(2.9–3.1)
Data express mean ± SD, lower bound-upper bound of 95% confi-
dence interval for the mean is given in parenthesis. *, &, #statistically 
significant differences vs. group A (p < 0.001), group B (p < 0.001) 
and group C (p = 0.03), respectively
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The endothelial cells show strong CD105 nuclear and 
cytoplasmic expression in groups A and B, a moderate 
expression in groups C and D, and a weak expression 
in group E. The endothelial cells of UA present 
a moderate cytoplasmic CD29 immunoexpression 
in group A while the other groups showed a weak 
Figure 1. Immunoexpression of CD105- and CD 29-positive MSCs in amniotic membrane (AM) and Wharton’s jelly (WJ) 
of umbilical cords from mothers of different ages. The H & E staining (A–E) revealed that WJ is formed of gelatinous 
ground substance with sparse collagen bundles (star) and stellate fibroblasts (arrow) and covered by amniotic epithelium 
(arrowhead). MSCs in AM & WJ show cytoplasmic and nuclear CD105 immunoexpression (brown color) which intensity 
decreased in older age groups (F–J). MSCs in AM & WJ show only cytoplasmic CD29 immunoexpression (K–O) that was 
also reduced with age. Bars — 50 mm, in inserts — 20 mm, total magnification ×400, inserts ×1000
A F K
B G L
C H M
D I N
E J O
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expression of this antigen. MSCs showed cytoplasmic 
and nuclear CD105 immunoexpression as well as 
cytoplasmic CD29 immunoexpression that appear to 
be reduced in the older age groups.
Figure 3 shows that endothelial cells in the wall of 
umbilical vein (UV) exhibit strong nuclear and cyto-
plasmic CD105 expression in groups A, B and C, and 
a moderate expression in groups D and E. The en-
Figure 2. Immunoexpression of CD105- and CD 29-positive MSCs in umbilical cord arteries from mothers of different 
ages. Sections stained with H & E (A–E) show endothelial cells (thin arrow) of tunica intima, and tunica media formed of 
elastic and smooth muscles (star). Tunica adventitia is not seen at this magnification. MSCs show cytoplasmic and nuclear 
CD105 immunoexpression (brown color) (F–J) as well as cytoplasmic CD29 immunoexpression (K–O) that appear to be 
reduced in the older age groups. Bars and magnifications as in the legend to Figure 1
A F K
B G L
C H M
D I N
E J O
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Figure 3. Immunoexpression of CD105- and CD 29-positive MSCs in umbilical cord veins from mothers of different ages. 
Sections stained with H & E (A–E) show endothelial cell (thin arrow) lining and thick muscular layer (star). MSCs show 
stronger nuclear and cytoplasmic CD105 immunoexpression (brown color) (F–J), and cytoplasmic CD29 immunoexpres-
sion (K–O) in veins of the young age groups compared to the older ones (×400, insert ×1,000)
dothelial cells also showed a moderate cytoplasmic 
CD29 expression in group A while in the other groups 
they showed a weak expression. MSCs showed stronger 
nuclear and cytoplasmic CD105 immunoexpression, and 
cytoplasmic CD29 immunoexpression in umbilical veins 
of the young age groups compared to the older ones.
Semiquantitative assessment of CD105  
and CD29 immunoreactivity 
Data presented in Table 2 show a significant de-
crease related to maternal age in the area percent 
(AP) and mean intensity (MI) of CD105 and CD29 
A F K
B G L
C H M
D I N
E J O
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Table 2. Area percent (AP) and mean intensity (MI) of CD105 and CD29 immunoexpression in MSCs of the amniotic 
membrane and Wharton’s jelly of umbilical cord
Age groups AP MI (lum)
CD105 CD29 CD105 CD29
Group A (20–25 years, n = 20) 1.83 ± 0.48
(1.61–2.06)
4.43 ± 0.94
(3.99–4.88)
177.4 ± 5.5
(174.8–179.9)
185.2 ± 10.4
(180.3–189.9)
Group B (26–30 years, n = 20) 1.45 ± 0.46
(1.23–1.67)
4.25 ± 0.99
(3.78–4.71)
168.9 ± 11.04
(163.7–174.1)
173.8 ± 19.5
(164.2–182.9)
Group C (31–35 years, n = 20) 0.89 ± 0.74
(0.54–1.23)
p1 < 0.001
p2 = 0.004
3.45 ± 0.68
(3.13–3.77)
p1 < 0.001
p2 = 0.007
133.5 ± 11.3
(81.91–89.22)
p1 < 0.001
p2 < 0.001
131.7 ± 14.6
(124.8–138.5)
p1 < 0.001
p2 < 0.001
Group D (36–40 years, n = 20) 0.46 ± 0.24
(0.34–0.58)
p1 < 0.001
p2 < 0.001
p3 = 0.02
1.43 ± 0.39
(1.25–1.6)
p1 < 0.001
p2 < 0.001
p3 < 0.001
85.57 ± 8.03
(81.9–89.2)
p1 < 0.001
p2 < 0.001
p3 < 0.001
70.7 ± 17.5
(62.7–78.7)
p1 < 0.001
p2 < 0.001
p3 = 0.001
Group E (41–45 years, n = 20) 0.30 ± 0.12
(1.2–1.7)
p1 < 0.001
p2 < 0.001
p3 = 0.003
p4 = 0.01
0.42 ± 0.28
(0.28–0.56)
p1 < 0.001
p2 < 0.001
p3 < 0.001
p4 < 0.001
68.4 ± 13.6
(61.9–74.9)
p1 < 0.001
p2 < 0.001
p3 < 0.001
p4 < 0.001
38.3 ± 10.1
(33.4–43.2)
p1 < 0.001
p2 < 0.001
p3 < 0.001
p4 < 0.001
Data are expressed as mean ± SD, (lower bound-upper bound of 95% confidence interval for the mean). p1, p2, p3, and p4 show significant diffe-
rences vs. groups A, B, C, and D, respectively. Significance was considered at p < 0.05
immunoexpression in the AM and WJ except for the 
group B that did not differ significantly from group A 
(Table 2). Regarding the UA (Table 3), there was 
a significant decrease in AP and MI of CD105 and 
CD 29 immunoexpression in the groups C, D and E 
compared to group A as well as in the groups D and E 
compared to the group C. A significant decrease 
in these parameters was observed also in group E 
compared to the group D (Table 3). 
In the umbilical vein (Table 4) there was a significant 
decrease in AP of CD105 and CD 29 immunoexpression 
in the groups D, E compared with groups A as well as in 
the group E compared to D. The MI of CD105 and CD 
29 immunoexpression in the groups C, D, E also showed 
significant decrease compared with groups A as well as 
in the group E compared to D (Table 4).
We found significantly negative correlations 
(Table 5) between the maternal age and AP and MI 
of both CD105 and CD29 immunoexpression in the 
studied components of the umbilical cord (AM and 
WJ, UA and UV). Moreover, it was found that CD105 
positive MSCs were expressed with maximal intensity 
in the UA with no significant difference compared to 
UV whereas this expression was significantly reduced 
(p < 0.001) in the AM and WJ. On the other hand, 
CD29 positive MSCs were maximally expressed in 
the WJ and AM and were significantly less intense 
expressed in UA and UV (Table 6).
Expression of the CD105 and CD29  
genes in umbilical cord components
In the amniotic membrane and Wharton’s jelly of the 
umbilical cord, mRNA levels of CD105 and CD29 
were significantly (p < 0.001) decreased in groups 
C (~2 fold/CD105 and ~1.5 fold/CD29), D (~3.5 
fold/CD105 and ~2.5 fold/CD29), and E (~3.5 fold/ 
/CD105 and ~3 fold/CD29) in comparison to group A. 
In addition, there was a significant decrease in the 
expression of CD105 and CD29 genes in groups D 
(p = 0.004, p < 0.001) and E (p = 0.005, p < 0.001) 
as compared to group C (Figure 4A).
Data presented in the Figure 4B show that CD105 
mRNA levels were lower in the umbilical artery of the 
groups C (~1.5 fold), D (~2 fold) and E (~5 fold) 
as compared to group A. There was also a significant 
decrease (p = 0.008, p < 0.001) of this gene expres-
sion between groups D and E compared to group C. 
CD29 mRNA levels were lower in groups D (~2.5 
fold/CD29) and E (~2.5 fold/CD29) as compared to 
group A (Figure 4B).
In the umbilical veins, CD105 and CD29 gene 
expression was decreased in groups D (both ~1.5 
fold) and E (~3.5 fold for CD105 and ~1.5 fold for 
CD29) as compared to group A. The expression of 
both genes was also lower in UVs in groups D and E 
compared to group C (Figure 4C).
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Table 4. Area percent (AP) and mean intensity (MI) of CD105 and CD29 immunoexpression in MSCs of the umbilical 
vein of different age groups
Age groups AP MI (lum)
CD105 CD29 CD105 CD29
Group A (20–25 years, n = 20) 3.45 ± 0.52
(3.35–3.55)
0.81 ± 0.6
(0.78–0.84)
180.3 ± 7.1
(176.9–183.6)
103.6 ± 11.9
(98.1–109.2)
Group B (26–30 years, n = 20) 3.63 ± 0.53
(3.19–3.52)
0.57 ± 0.13
(0.51–0.63)
174.5 ± 6.4
(171.5–177.6)
98.1 ± 9.5
(98.1–54.6)
Group C (31–35 years, n = 20) 3.34 ± 0.25
(3.22–3.45)
0.51 ± 0.31
(0.07–0.11)
171.5 ± 8.4
(167.5–175.4)
p1 = 0.003
50.7 ± 4.2
(48.8–109.2)
p1 < 0.001
Group D (36–40 years, n = 20) 2.27 ± 0.34
(2.12–2.43)
p1 < 0.001
p2 < 0.001
p3 < 0.001
0.07 ± 0.03
(0.06–0.08)
p1 < 0.001
p2 < 0.001
p3 < 0.001
166.1 ± 8.9
(162.1–170.3)
p1 < 0.001
p2 = 0.005
50.7 ± 4.2
(48.77–52.7)
p1 < 0.001
p2 = 0.001
p3 < 0.001
Group E (41–45 years, n = 20) 1.03 ± 0.019
(1.05–1.05)
p1 < 0.001
p2 < 0.001
p3 < 0.001
p4 < 0.001
0.06 ± 0.03
(0.06–0.08)
p1 < 0.001
p2 < 0.001
p3 < 0.001
144.3 ± 5.2
(141.7–146.8)
p1 < 0.001
p2 < 0.001
p3 < 0.001
p4 = 0.001
33.7 ± 6.7
(30.4–36.9)
p1 < 0.001
p2 < 0.001
p3 < 0.001
p4 = 0.001
Data are expressed as mean ± SD, (lower bound-upper bound of 95% confidence interval for the mean). p1, p2, p3, and p4 show significant diffe-
rences vs. groups A, B, C, and D, respectively. Significance was considered at p < 0.05
Table 3. Area percent (AP) and mean intensity (MI) of CD105 and CD29 immunoexpression in MSCs of the umbilical 
artery of different age groups
Age groups AP MI (lum)
CD105 CD29 CD105 CD29
Group A (20–25 years, n = 20) 4.53 ± 1.12
(4–5.06)
0.49 ± 0.18
(0.36–0.63)
191.3 ± 6.7
(188.1–194.4)
118.7 ± 9.3
(114.3–123.1)
Group B (26–30 years, n = 20) 3.87 ± 1.23
(3.30–4.45)
0.45 ± 0.18
(0.37–0.54)
186.5 ± 6.4
(183.1–189.6)
113.1 ± 23.2
(109.1–117.1)
Group C (31–35 years, n = 20) 3.20 ± 0.61
(2.92–3.49)
p1 < 0.001
0.37 ± 0.16
(0.20–0.54)
p1 = 0.03
180.2 ± 7.4
(176.7–183.6)
p1 < 0.001
58.2 ± 10.1
(35.4–62.9)
p1 < 0.001
p2 < 0.001
Group D (36–40 years, n = 20) 2.17 ± 0.37
(2.91–3.49)
p1 < 0.001
p2 < 0.001
p3 < 0.001
0.19 ± 0.11
(0.07–0.28)
p1 = 0.004
p2 < 0.001
178.1 ± 8.9
(174.1–182.2)
p1 < 0.001
p2 = 0.003
39.7 ± 6.8
(36.7–42.8)
p1 < 0.001
p2 < 0.001
p3 < 0.001
Group E (41–45 years, n = 20) 0.94 ± 0.30
(0.79–1.08)
p1 < 0.001
p2 < 0.001
p3 < 0.001
p4 < 0.001
0.12 ± 0.10
(0.07–0.25)
p1 < 0.001
p2 < 0.001
p3 = 0.03
p4 = 0.04
156.3 ± 5.2
(153.7–158.8)
p1 < 0.001
p2 < 0.001
p3 < 0.001
p4 < 0.001
28.5 ± 5.4
(25.8–31.1)
p1 < 0.001
p2 < 0.001
p3 < 0.001
p4 < 0.001
Data are expressed as mean ± SD (lower bound-upper bound of 95% confidence interval for the mean). p1, p2, p3, and p4 show significant diffe-
rences vs. groups A, B, C, and D, respectively. Significance was considered at p < 0.05
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As presented in Figure 5 in the three studied com-
ponents of the umbilical cord CD105 showed highest 
mRNA level in UA (2.22 ± 0.1) and UV (2.13 ± 0.1), 
and the lowest level in the AM and WJ (0.588 ± 0.05). 
CD29 expression was the highest in UV (1.01 ± 0.05), 
moderate in AM and WJ (0.686 ± 0.07) and lowest 
in UA (0.252 ± 0.05) 
Discussion
The results of this study show that CD105-, CD29-po-
sitive and CD34-negative MSCs present in the major 
components of human umbilical cord (AM and WJ, 
UA and UV) and this finding is supported by some 
previous studies [1, 4, 5, 25–27]. It was an interesting 
observation that endothelial lining of both the UA 
and UV showed expression of the MSCs markers 
CD29 and CD105. In a previous study of Fonsatti et 
al. endoglin (also known as CD105) was described 
to be highly expressed on proliferating vascular en-
dothelial cells [28]. 
In the present data, a significant decrease in the 
AP of both CD105 and CD29 immunoexpression in 
the different studied area of the UC was observed in 
the older age groups compared with the younger ones 
indicated a significant reduction in the amount of cells 
expressing these markers. In addition, a significant 
decrease was observed in both CD105 and CD29 
immunoexpression in the older groups compared 
to the younger ones which indicated a significant 
reduction in expression level of individual cells. 
A significant negative correlations existed between 
Table 5. Correlations between maternal age and CD105 and CD29 immunoexpression in MSCs in different parts of umbi-
lical cord
Parameter Maternal age
AP MI
r P value r P value
CD105
AM and WJ –0.741 p < 0.001 –0.932 p < 0.001
UA –0.841 p < 0.001 –0.780 p < 0.001
UV –0.844 p < 0.001 –0.771 p < 0.001
CD29
AM and WJ –0.865 p < 0.001 –0.937 p < 0.001
UA –0.471 p < 0.001 –0.927 p < 0.001
UV –0.871 p < 0.001 –0.902 p < 0.001
AP — area percent; MI — mean intensity; AM — amniotic membrane; WJ — Wharton’s jelly; AU — umbilical artery; UV — umbilical vein. 
Significance was considered at p < 0.05
Table 6. Immunoexpression of CD105 and CD29 MSCs markers in different areas of human umbilical cord of all studied 
cases
Area MSCs markers (n = 100)
CD105 CD29
AP MI AP MI
AM and WJ 0.99 ± 0.75
(0.84–1.13)
126.9 ± 44.7
(118.1–135.8)
2.81 ± 1.74
(2.4–3.1)
120.3 ± 58.9
(108.5–131.9)
UA 2.95 ± 1.49
(2.66–3.25)
p1 < 0.001
178.7 ± 43.7
(175.9–181.5)
p1 < 0.001
0.33 ± 0.28
(0.27–0.38)
p1 < 0.001
71.8 ± 38.3
(64.2–79.4)
p1 < 0.001
UV 2.70 ± 0.96
(2.51–2.89)
p2 < 0.001
167.6 ± 44.2
(164.7–170.4)
p2 < 0.001
0.32 ± 0.31
(0.25–0.38)
p2 < 0.001
66.3 ± 30.1
(60.4–72.3)
p2 < 0.001
Data are expressed as mean ± SD (lower bound-upper bound of 95% confidence interval for the mean). p1 and p2 shows significance of UA and UV vs. 
AM and WJ, respectively. Significance was considered at p < 0.05
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the maternal age and both CD105 and CD29 im-
munoexpression, in term of AP and MI, in different 
areas of the UC. Validation of immunohistochemical 
results was performed by quantitative RT-PCR which 
revealed a significant decrease in CD105 and CD29 
genes expression in older ages compared with the 
younger ones. This finding could justify the reduction 
observed in the MSCs markers expression. Although 
RT-PCR was used frequently to assess the expression 
of MSCs CD105 [29–31] and CD29 genes [32] in hu-
man umbilical vein cells and placenta-derived stem 
cells, no previous studies have investigated in depth 
the impact of age on such MSCs gene expression in 
general or in umbilical cord stem cells in particular. 
In a previous experimental study, Asumda and Chase 
[33] have observed that the expression profile of Oct-4, 
Sox-2 and NANOG in the adult BM-MSCs derived 
from the bone marrow of old rats was significantly 
lower in comparison to that observed in the young 
MSC cultures. Only one study characterized human 
MSCs isolated from UC of different donors and did 
extensive testing on these cells to compare their pro-
liferative, colony forming capacity and differentiation 
potential [14]. Our results partially support the data of 
Huang et al. [13], who reported that UCMSCs from 
young women may have a higher amount of cells that 
displayed positive markers for MSCs (CD44, CD90, 
and CD105) compared to the older ones although 
this difference was not statistically signiﬁcance. The 
latter could be attributed to the small sample size of 
their study (five mothers in each group).
Huang et al. [13] implied that the umbilical cord 
from younger donor represents a relatively effective 
source of MSCs. They speculated that cells from 
umbilical cords of elder donor exhibit reduced 
differentiation capability and this might have been 
attributed to a declined functional status of older 
mothers’ organs which provide a supportive role and 
a microenvironment that enables development of 
UCMSCs. The results of some ultrastructural and bio-
chemical studies make it clear that the structure and 
function of the cytoplasmic organelles, particularly 
mitochondria, of both the oocytes and the granulosa 
cells, which are critical for fertilization and normal 
embryonic development, are markedly compromised 
in the oocytes of older women [34]. This finding is 
supported by earlier studies on the ATP content [35] 
and ultrastructure of human oocytes [36] as well as 
murine [37], bovine [38] and hamster [39] oocytes. Ju 
and Rudolph reported that the level of telomerase 
Figure 4. Real-time PCR analysis of the expression of CD105 and CD29 genes in amniotic membrane and Wharton’s jelly 
(A), umbilical artery (B), and umbilical vein (C) isolated from human umbilical cord from mothers of various ages. The 
age of mothers was 20–25, 26–30, 31–35, 36–40 and 45–48 in groups A, B, C, D and E, respectively. The housekeeping 
gene b-actin was used as an internal reference for normalization. Data are expressed as mean fold of change ± SEM  
(n = 20). *p < 0.05 vs. group A
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activity is not sufficient to maintain telomere length 
of stem cells during aging with increased sensitivity 
towards senescence or apoptosis induced by telomere 
shortening [40]. Such findings may at least partly ex-
plain the observed decrease in the expression levels 
of CD105 and CD29 in UC-MSCs with increased age. 
The effect of age on adult stem cells was reported 
in few previous studies. A decrease in the number 
of adult MSCs in the bone marrow with increasing 
age had been previously reported [41]. Wagner et al. 
also reported an increase in size of senescent MSCs 
and the attenuation of the expression of specific 
surface markers with increasing age [42]. Yu and 
Kang reported that the aging of adult MSCs leads to 
an age-associated decline in their number, function 
and properties of multilineage differentiation [43]. It 
was demonstrated that aging caused gene expression 
changes in human MSCs isolated from bone marrow 
or mobilized peripheral blood collected from donors 
of different ages [44]. These changes may be triggered 
by many factors including intense oxidative and meta-
bolic stress, chronic inflammation, enhanced telomere 
attrition and defects in DNA repair mechanisms [45]. 
Interestingly, the present study showed that the 
maximum expression of CD105 was observed in the 
wall of umbilical artery whereas that of CD29 was in 
the amniotic membrane and Wharton’s jelly. This 
differential distribution of umbilical cord MSCs which 
had not been previously reported may render the se-
lective isolation of these cells from the different areas 
of the UC an available option for cell therapy applica-
tions. Based on these findings, UA is recommended as 
a rich area of the UC with significantly large number 
of CD105 positive-MSCs while the AM and WJ have 
Figure 5. Comparison of the expression of CD105 and CD29 genes in amniotic layer and Wharton’s jelly (A1–E1), um-
bilical artery (A2–E2), and umbilical vein (A3–E3) of umbilical cords from mothers of various ages assessed by real-time 
PCR analysis. The age groups are the same as described for Figure 4. The housekeeping gene b-actin was used as an inter-
nal reference for normalization. Data are expressed as mean fold of change ± SEM (n = 20). *p < 0.05 vs. group A
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significantly large number of CD29-positive MSCs. 
Both areas may be easily collected from the UC.
In this study two surface antigen markers of MSCs 
were studied in a relatively large sample and another 
group of surface antigen markers could be considered 
in coming studies. Further studies to compare the 
differentiation and proliferation abilities of MSCs 
isolated from different areas of the UC of mothers 
with different ages are recommended.
In conclusion, the present study provided insights 
on the impact of the maternal age on CD105 and 
CD29 surface markers antigen and genes expressions 
as well as the anatomical localization of the umbilical 
cord MSCs. These results are of particular importance 
in the context of possible exchange of the UC-derived 
MSCs between cell banks, clinics and laboratories. 
Labeling the MSCs with the specific UC area from 
which the cells were taken as well as the mothers’ 
age may be important to improve the outcome of 
therapeutic applications. 
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